Affiliation:
1. Senior Resident (Dept of general surgery) ANMMCH, Gaya.
2. Associate Professor (HOD, Dept of general surgery) ANMMCH, Gaya.
Abstract
Carcinoma of the prostate (CaP) is currently the most frequently diagnosed cancer among males .
Although it was initially thought to be uncommon in Africans, recent studies have shown that the
incidence and prevalence rates are higher in Africans than in age-matched African-Americans. The clinical outcome is also
known to be relatively poor among blacks who typically present for treatment at advanced stages of the disease and at relatively younger ages .Before the advent of sophisticated diagnostic techniques, the diagnosis of carcinoma of prostate was
mainly done with digital rectal examination (DRE) with the attendant limitations as it was only useful in detecting advanced
diseases. Previous studies have also shown that the ndings and conclusions reached at DRE were subjective and observer dependent . The subsequent introduction of the transrectal ultrasound (TRUS), which was greeted with much expectation with the hope that it would assist in detecting cancer nodules eluding detection by DRE turned out to be a disappointment .
Nevertheless, the introduction of the serum prostate-specic antigen (PSA) test brought about a revolution in the diagnosis of
CaP since it allowed the detection of the disease in its early stages. This resulted in a signicant reduction in the number of
cases of CaP diagnosed at advanced stages. Since then, researchers have concentrated on the merits and demerits of the PSA in the early detection of CaP . In recent times, however, controversies have trailed the use of the PSA in the screening and early
diagnosis of CaP since it is becoming apparent that serum PSA estimation has some signicant drawbacks in the evaluation of patients with prostatic disorders . Although a larger percentage of cases of carcinoma of prostate are still being diagnosed at
advanced stages in most African nations, only extremely very few studies have examined the role of serum PSA in the management of such cases . Thus, the aim of this study was to compare the diagnostic yield of DRE, TRUS scan and PSA in the
diagnostic evaluation of advanced carcinoma.
Reference14 articles.
1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9‑29.
2. Odedina FT, Ogunbiyi JO, Ukoli FA. Roots of prostate cancer in African‑American men. J Natl Med Assoc 2006;98:539‑43.
3. Thompson IM, Ernst JJ, Gangai MP, Spence CR. Adenocarcinoma of the prostate: Results of routine urological screening. J Urol 1984;132:690‑2.
4. Lee F, Gray JM, McLeary RD, Meadows TR, Kumasaka GH, Borlaza GS, et al. Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and staging. Prostate 1985;7:117‑29.
5. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010;19:1893‑907.